Howard Kaufman, MD : Episode 7


Emerging Agents in the Pipeline for Merkel Cell Carcinoma

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.

Related Videos
Related Content